Crucell currently has vaccine and protein programs in various stages of development. Most of these are based on Crucell’s innovative PER.C6^® production technology. Core programs include vaccines against the Ebola virus, influenza, malaria and West Nile virus, as well as a rabies antibody product.

Crucell’s current pipeline programs comprise:

• Yellow Fever vaccine
• Malaria vaccine
• Tuberculosis vaccine
• Ebola vaccine
• HIV vaccine
• Influenza seasonal vaccines
• Influenza pandemic vaccines
• Rabies antibody cocktail
• Anti-bacterial antibodies

	PC	Phase			Filing	Expected Launch
		I	II	III
Rabies antibody cocktail
Anti-bacterial antibodies6

¹ Partnered with Aeras Foundation

² Partnered with VRC

³ Partnered with Harvard

⁴ Partnered with sanofi pasteur

⁵ Developed by sanofi pasteur, technology supplied by Crucell

⁶ Partnered with MedImmune

Information updated October 2007